首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1463953

動物抗生素和抗菌藥物市場 - 全球產業規模、佔有率、趨勢、機會和預測，按產品、交付方式、動物類型、地區和競爭細分，2019-2029F

Animal Antibiotics and Antimicrobials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Mode of Delivery, By Animal Type, By Region, and Competition, 2019-2029F

出版日期: 2024年04月15日 | 出版商:

TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球動物抗生素和抗微生物藥物市場估值為49 億美元，預計到2029 年，預測期內將出現強勁成長，複合年成長率為3.55%。的動物健康領域的一個充滿活力的領域工業，其特點是生產和分銷旨在預防和治療動物細菌感染的藥品。該市場涵蓋廣泛的產品，包括抗生素、抗菌劑和相關獸藥，這些產品用於各種牲畜和伴侶動物領域。

主要市場促進因素

對動物性蛋白質的需求不斷增加推動市場成長

牲畜傳染病的流行推動了市場的成長

畜牧業集約化推動市場成長

主要市場挑戰

抗菌素抗藥性 (AMR)

監理合規和市場准入

消費者偏好和市場動態

主要市場趨勢

專注於抗生素替代品和新療法

轉向精準畜牧業

對獸醫生物製品和免疫療法的需求不斷成長

細分市場洞察

產品洞察

區域洞察

Global Animal Antibiotics and Antimicrobials Market was valued at USD 4.90 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 3.55% through 2029. The Global Animal Antibiotics and Antimicrobials Market is a dynamic sector within the broader animal health industry, characterized by the production and distribution of pharmaceutical products aimed at preventing and treating bacterial infections in animals. This market encompasses a wide range of products, including antibiotics, antimicrobials, and related veterinary medicines, which are utilized across various livestock and companion animal segments.

Key Market Drivers

Increasing Demand for Animal Protein drives the Market Growth

The increasing demand for animal protein is a significant driver of growth in the Global Animal Antibiotics and Antimicrobials Market due to its direct impact on livestock production and the need for disease management. As the global population continues to grow, particularly in developing countries, there is a corresponding increase in demand for protein-rich diets. Animal protein, including meat, dairy, and eggs, is an essential component of many diets worldwide. Additionally, urbanization trends lead to changes in dietary habits, with urban populations consuming more animal protein as incomes rise and lifestyles become more westernized.

Economic development and globalization have led to shifts in dietary preferences, with consumers increasingly incorporating more animal protein into their diets. This trend is particularly evident in emerging economies where rising incomes and improved living standards enable greater access to animal protein products. As a result, there is growing demand for livestock products, driving expansion in animal production systems. Animal protein is rich in essential amino acids, vitamins, and minerals, making it an important source of nutrition for human health and development. Meat, dairy, and eggs provide high-quality protein that supports muscle growth, immune function, and overall health. Consequently, there is sustained demand for animal protein to meet dietary requirements and nutritional needs across diverse demographic groups.

Livestock farming plays a crucial role in ensuring food security and livelihoods for millions of people worldwide, particularly in rural areas. Smallholder farmers rely on animal agriculture for income generation, employment opportunities, and food production. To meet the growing demand for animal protein, farmers often intensify their production systems, increasing herd sizes and productivity. However, intensified farming practices also raise the risk of disease outbreaks, necessitating the use of antibiotics and antimicrobials for disease prevention and control.The globalization of food supply chains has facilitated the widespread distribution of animal protein products across regions and continents. Livestock products are traded internationally, allowing consumers to access a diverse range of animal protein sources year-round. However, this interconnectedness also poses challenges in terms of disease transmission and biosecurity risks. Antibiotics and antimicrobials are used to mitigate these risks, safeguarding animal health and ensuring the safety and quality of food products throughout the supply chain.

Theincreasing demand for animal protein drives growth in the Global Animal Antibiotics and Antimicrobials Market by stimulating expansion in livestock production systems and intensification of farming practices. As the demand for meat, dairy, and eggs continues to rise globally, the need for effective disease management becomes paramount, leading to greater utilization of antibiotics and antimicrobials in animal agriculture. Understanding the complex interplay between dietary trends, economic factors, and food security considerations is essential for stakeholders in the animal health industry to navigate market dynamics and capitalize on growth opportunities.

Prevalence of Infectious Diseases in Livestock Drives the Market Growth

The prevalence of infectious diseases in livestock is a significant driver of growth in the Global Animal Antibiotics and Antimicrobials Market due to its direct impact on animal health, productivity, and economic sustainability in the livestock industry. The intensification of livestock production, characterized by higher stocking densities, larger herd sizes, and confinement systems, creates conducive environments for the spread of infectious diseases. Close proximity between animals facilitates the transmission of pathogens, leading to increased disease incidence and prevalence. Intensive farming practices are common in modern animal agriculture, particularly in sectors such as poultry, swine, and aquaculture, where high levels of production efficiency are sought.

The globalization of food supply chains has led to the movement of livestock, animal products, and genetic materials across borders, facilitating international trade. However, this interconnectedness also increases the risk of introducing and spreading infectious diseases across regions and continents. Livestock diseases such as avian influenza, foot-and-mouth disease, and African swine fever can have devastating effects on animal populations and agricultural economies. In response to disease outbreaks, antibiotics and antimicrobials are often used for disease control and prevention, driving demand within the animal health market. Environmental conditions, including temperature, humidity, and air quality, can influence the prevalence and severity of infectious diseases in livestock. Stressors such as overcrowding, poor ventilation, and inadequate sanitation compromise animal immune systems, making them more susceptible to infections. Moreover, environmental contamination with pathogenic microorganisms, such as bacteria, viruses, and parasites, can serve as reservoirs for disease transmission within livestock facilities. Antibiotics and antimicrobials are employed to mitigate these environmental risks and maintain animal health and welfare.

Wild and feral animals, insects, rodents, and other wildlife species can act as reservoirs or vectors for infectious diseases, introducing pathogens into livestock populations. For example, ticks, mosquitoes, and flies can transmit diseases such as Lyme disease, West Nile virus, and African trypanosomiasis to livestock. Wildlife reservoirs may harbor zoonotic pathogens capable of infecting both animals and humans, posing public health risks. Antibiotics and antimicrobials are used to control vector populations and manage disease transmission pathways, reducing the incidence of infectious diseases in livestock. Implementation of biosecurity measures is essential for preventing and controlling the spread of infectious diseases within livestock operations. Biosecurity protocols encompass practices such as quarantine, vaccination, hygiene management, and restricted access to farm facilities. Despite best efforts to maintain biosecurity, disease outbreaks may still occur due to lapses in protocols or unforeseen circumstances. Antibiotics and antimicrobials serve as important tools for disease management in such situations, helping to contain outbreaks and minimize economic losses.

Theprevalence of infectious diseases in livestock drives growth in the Global Animal Antibiotics and Antimicrobials Market by necessitating the use of pharmaceutical interventions for disease prevention, control, and treatment. As livestock producers seek to safeguard animal health, ensure production continuity, and maintain economic viability, they rely on antibiotics and antimicrobials to mitigate the impact of infectious diseases on their operations. Understanding the complex interactions between environmental factors, disease dynamics, and biosecurity practices is crucial for effectively managing disease risks and optimizing antibiotic use in animal agriculture.

Intensification of Livestock Farming Practices Drives the Market Growth

The intensification of livestock farming practices is a significant driver of growth in the Global Animal Antibiotics and Antimicrobials Market due to its direct influence on animal health, productivity, and disease management. Intensification refers to the process of increasing production efficiency and output within a given agricultural area or facility. Intensification aims to maximize production efficiency and profitability by optimizing resource utilization, minimizing production costs, and increasing output per unit of land or labor. In intensive livestock systems, such as confined animal feeding operations (CAFOs) and high-density aquaculture facilities, animals are raised in controlled environments with specialized housing, feeding, and management practices. These systems enable producers to achieve higher stocking densities and faster growth rates, leading to increased productivity and economies of scale.

Intensification often involves scaling up the size and scope of livestock operations to meet growing demand for animal protein products. Large-scale commercial farms and integrated production systems dominate the global livestock industry, particularly in sectors such as poultry, swine, and dairy. These operations require efficient disease management strategies to maintain the health and productivity of large animal populations. Antibiotics and antimicrobials are used prophylactically and therapeutically to prevent disease outbreaks, control infections, and optimize growth performance in intensive production environments. Advances in agricultural technology, genetics, nutrition, and management practices have enabled greater intensification of livestock farming systems. Innovations such as genetically improved breeds, precision nutrition, automated feeding systems, and climate-controlled housing facilities contribute to higher productivity and efficiency in animal production. However, these technological advancements also create challenges related to disease management, as intensive farming practices can increase stress levels, disease susceptibility, and pathogen transmission among animals. Antibiotics and antimicrobials are essential tools for mitigating these risks and maintaining animal health in intensive production settings.

Rising global demand for animal protein, driven by population growth, urbanization, and changing dietary habits, incentivizes producers to intensify their farming practices to meet market demand. Consumers expect a consistent supply of high-quality meat, dairy, and eggs throughout the year, regardless of seasonal variations or geographic constraints. Intensive production systems enable producers to meet these demands by optimizing production schedules, reducing time to market, and ensuring product consistency. However, intensive farming practices may also raise concerns among consumers regarding animal welfare, antimicrobial use, and environmental sustainability. Regulatory agencies and industry stakeholders are implementing measures to address these concerns, promoting responsible antibiotic stewardship, alternative disease management strategies, and sustainable production practices. Intensive livestock farming environments are susceptible to disease outbreaks due to high stocking densities, close animal contact, and shared environmental resources. Biosecurity measures, such as strict hygiene protocols, vaccination programs, and quarantine procedures, are essential for preventing and controlling the spread of infectious diseases within intensive production facilities. Despite best efforts to maintain biosecurity, disease outbreaks may still occur, necessitating the use of antibiotics and antimicrobials for disease treatment and control. Prophylactic and metaphylactic antibiotic use is common in intensive livestock systems to prevent disease outbreaks and maintain herd health.

Theintensification of livestock farming practices drives growth in the Global Animal Antibiotics and Antimicrobials Market by increasing the demand for pharmaceutical interventions for disease prevention, control, and treatment. As producers strive to maximize production efficiency, meet market demands, and ensure economic viability, they rely on antibiotics and antimicrobials to mitigate disease risks and maintain the health and productivity of intensively managed animal populations. Understanding the complex interactions between technological advancements, market dynamics, regulatory frameworks, and disease management strategies is essential for addressing challenges associated with antibiotic use in intensive livestock production systems and promoting sustainable agricultural practices.

Key Market Challenges

Antimicrobial Resistance (AMR)

Antimicrobial resistance poses a significant challenge to the Global Animal Antibiotics and Antimicrobials Market. Overuse and misuse of antibiotics in animal agriculture contribute to the emergence and spread of antimicrobial-resistant bacteria. AMR diminishes the effectiveness of antibiotics, leading to treatment failures, increased healthcare costs, and compromised animal and human health outcomes. The transmission of antimicrobial-resistant pathogens from animals to humans through food consumption, direct contact, or environmental contamination further exacerbates public health risks.

Addressing AMR requires a multifaceted approach that emphasizes prudent antibiotic use, enhanced surveillance and monitoring, development of alternative disease management strategies, and promotion of antimicrobial stewardship programs. Regulatory agencies worldwide are implementing measures to mitigate AMR in animal agriculture, including restrictions on the use of medically important antibiotics for growth promotion purposes, veterinary oversight requirements, and surveillance programs to monitor antimicrobial resistance trends. Market players are also investing in research and development to develop novel antibiotics, antimicrobial alternatives, and vaccines that can help combat AMR and maintain the efficacy of antimicrobial therapies.

Regulatory Compliance and Market Access

Stringent regulatory frameworks govern the use of antibiotics and antimicrobials in animal agriculture, imposing compliance requirements on manufacturers, distributors, veterinarians, and livestock producers. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), establish guidelines, standards, and approval processes for veterinary pharmaceuticals to ensure product safety, efficacy, and quality. Compliance with regulatory requirements is essential for market access, product registration, and commercialization of antibiotics and antimicrobials.

Regulatory constraints can pose challenges for market players in terms of product development, registration timelines, and manufacturing practices. Delays in regulatory approvals, changes in regulatory requirements, and product recalls due to non-compliance can disrupt supply chains, increase operational costs, and hinder market expansion. Market players must navigate complex regulatory landscapes, demonstrate product safety and efficacy, and adhere to Good Manufacturing Practices (GMP) to achieve regulatory compliance and maintain market access.

Consumer Preferences and Market Dynamics

Changing consumer preferences and market dynamics pose challenges for the Global Animal Antibiotics and Antimicrobials Market. Increasing consumer awareness about animal welfare, food safety, and sustainability concerns has led to shifting preferences towards antibiotic-free and organic animal products. Consumers are demanding transparency, traceability, and ethical sourcing practices throughout the food supply chain, influencing purchasing decisions and brand loyalty.

Market dynamics such as price volatility, supply chain disruptions, and competitive pressures also impact the demand for antibiotics and antimicrobials in animal agriculture. Fluctuations in input costs, trade policies, and market competition can affect product pricing, profitability, and market share. Market players must adapt to changing consumer preferences, market dynamics, and regulatory requirements by diversifying product portfolios, adopting sustainable production practices, and engaging in transparent communication with stakeholders.

Key Market Trends

Focus on Antibiotic Alternatives and Novel Therapies

With increasing concerns about antimicrobial resistance (AMR) and the need to reduce reliance on traditional antibiotics, there is a growing interest in developing and adopting alternative disease management strategies in animal agriculture. Antibiotic alternatives such as probiotics, prebiotics, phytogenics, enzymes, organic acids, and essential oils are gaining traction as viable options for promoting animal health, improving immune function, and enhancing disease resistance. These alternatives offer potential benefits such as improved gut health, enhanced nutrient utilization, and reduced environmental impact compared to antibiotics.

Additionally, there is ongoing research and development focused on novel therapies and innovative treatment modalities for controlling infectious diseases in livestock. This includes the development of new antimicrobial agents, bacteriophages, immune modulators, and gene editing technologies that target specific pathogens or enhance host immunity. These advancements in veterinary medicine aim to provide effective alternatives to traditional antibiotics while addressing AMR concerns and promoting sustainable animal production practices.

Shift Towards Precision Livestock Farming

Precision livestock farming (PLF) is an emerging approach that leverages technology, data analytics, and automation to monitor, manage, and optimize animal production systems in real-time. PLF encompasses a range of technologies such as sensors, wearable devices, drones, smart farming equipment, and data analytics platforms that enable precise monitoring of animal health, behavior, performance, and environmental conditions. By harnessing big data and artificial intelligence (AI) algorithms, PLF systems can provide insights into disease risk factors, early detection of health issues, and targeted interventions to improve animal welfare and productivity.

The adoption of PLF technologies offers several potential benefits for disease management and antibiotic use reduction in livestock farming. For example, real-time monitoring of animal behavior and physiological parameters can help identify signs of illness or distress, enabling prompt intervention and treatment without the need for prophylactic antibiotics. Furthermore, PLF systems enable personalized management approaches tailored to individual animal needs, optimizing feed efficiency, minimizing stress, and reducing disease susceptibility.

Rising Demand for Veterinary Biologics and Immunotherapies

There is a growing recognition of the importance of vaccination and immunotherapy in preventing and controlling infectious diseases in animals. Veterinary biologics, including vaccines, antibodies, and immunomodulators, play a crucial role in stimulating immune responses, conferring protective immunity, and reducing the reliance on antibiotics for disease treatment. The global market for veterinary biologics is expected to expand significantly as demand for preventive healthcare solutions in animal agriculture continues to rise.

Key trends driving growth in the veterinary biologics market include the development of next-generation vaccines with improved efficacy, safety, and duration of immunity, as well as the expansion of vaccine portfolios targeting emerging and zoonotic diseases. Additionally, there is growing interest in immunotherapies such as monoclonal antibodies, immune checkpoint inhibitors, and cytokine therapies for the treatment of infectious and chronic diseases in animals. These immunotherapeutic approaches offer novel strategies for combating pathogens, modulating immune responses, and reducing reliance on antimicrobials in veterinary medicine.

Segmental Insights

Product Insights

Based on the category of Product, the Penicillins segment emerged as the dominant player in the global market for Animal Antibiotics and Antimicrobials in 2023.Penicillins are one of the oldest and most commonly used classes of antibiotics in both human and veterinary medicine. They are effective against a wide range of gram-positive bacteria, including Streptococcus, Staphylococcus, and Clostridium species. Penicillins exert their antibacterial activity by interfering with bacterial cell wall synthesis, leading to cell lysis and death.

In veterinary medicine, penicillins are used to treat bacterial infections in livestock, poultry, and companion animals. They are available in various formulations, including injectables, oral medications, and topical preparations. Penicillin derivatives such as amoxicillin and ampicillin are frequently used in veterinary practice due to their efficacy, safety, and relatively low cost.

While penicillins remain important antibiotics in animal health, their dominance in the Global Animal Antibiotics and Antimicrobials Market has been challenged by factors such as antimicrobial resistance, regulatory restrictions, and the availability of alternative antibiotics. Nevertheless, penicillins continue to be widely used for the treatment of common bacterial infections in animals, particularly in regions where they are cost-effective and readily accessible.These factors are expected to drive the growth of this segment.

Regional Insights

Asia Pacific emerged as the dominant player in the global Animal Antibiotics and Antimicrobials market in 2023, holding the largest market share in terms of value.The Asia Pacific region hosts a diverse livestock industry, comprising poultry, swine, cattle, aquaculture, and companion animals. Nations like China, India, Vietnam, Indonesia, and Thailand boast large livestock populations, significantly contributing to global meat, dairy, and aquaculture output. The region's extensive and varied livestock sector fuels substantial demand for animal antibiotics and antimicrobials, essential for disease management, productivity optimization, and animal welfare. In recent years, there's been a swift expansion of intensive livestock farming practices, especially in urbanizing, industrializing, and economically growing countries. These systems, including confined animal feeding operations (CAFOs) and high-density poultry, swine, and aquaculture facilities, rely heavily on antibiotics and antimicrobials for disease prevention, control, and treatment, driving notable demand within the animal health market.

The Asia Pacific's rising incomes, urbanization, and evolving dietary preferences have spurred heightened demand for animal protein, encompassing meat, eggs, dairy, and seafood. As consumers seek affordable, high-quality protein sources, the region witnesses a surge in demand for livestock products. To meet this rising need, livestock producers depend on antibiotics and antimicrobials to maintain animal health, ensure continuous production, and adhere to food safety standards. Consequently, the Asia Pacific commands a significant share of global antibiotic consumption in animal agriculture.

TheAsia Pacific has experienced remarkable growth in its veterinary pharmaceutical sector, fueled by increasing demand for animal health products, augmented RD investments, and expanded distribution networks. Local and multinational pharmaceutical firms actively develop, manufacture, and market a diverse range of veterinary medicines, including antibiotics and antimicrobials, catering to the burgeoning livestock industry. Additionally, governments across the region implement regulatory reforms and quality standards to guarantee the safety, efficacy, and responsible usage of veterinary pharmaceuticals, further propelling market expansion.

Key Market Players

Boehringer Ingelheim International GmbH

Zoetis Services LLC

Merck co. Inc

Elanco Animal Health Incorporated

Phibro Animal Health Corporation

Vetoquinol S.A.

Virbac S.A.

HIPRA S.A.

Ceva Sante Animale S.A.

Kyoritsuseiyaku Corporation

Report Scope:

In this report, the Global Animal Antibiotics and Antimicrobials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Antibiotics and Antimicrobials Market,By Product:

Tetracycline
Penicillin
Sulfonamide
Macrolide
Cephalosporin
Lincosamide

Animal Antibiotics and Antimicrobials Market,By Mode of Delivery:

Premixes
Oral Solutions
Injection

Animal Antibiotics and Antimicrobials Market,By Animal Type:

Food Producing
Companion

Animal Antibiotics and Antimicrobials Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Antibiotics and Antimicrobials Market.

Available Customizations:

Global Animal Antibiotics and Antimicrobials market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1.Product Overview

1.1.Market Definition
1.2.Scope of the Market
- 1.2.1.Markets Covered
- 1.2.2.Years Considered for Study
- 1.2.3.Key Market Segmentations

2.Research Methodology

2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validation
2.7.Assumptions and Limitations

3.Executive Summary

3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends

4.Voice of Customer

5.GlobalAnimal Antibiotics and Antimicrobials MarketOutlook

5.1.Market Size Forecast
- 5.1.1.By Value
5.2.Market Share Forecast
- 5.2.1.By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Lincosamide)
- 5.2.2.By Mode of Delivery (Premixes, oral Solutions, Injection)
- 5.2.3.By Animal Type (Food Producing, Companion)
- 5.2.4.By Region
- 5.2.5.By Company (2023)
5.3.Market Map

6.North America Animal Antibiotics and Antimicrobials Market Outlook

6.1.Market Size Forecast
- 6.1.1.By Value
6.2.Market Share Forecast
- 6.2.1.ByProduct
- 6.2.2.By Mode of Delivery
- 6.2.3.By Animal Type
- 6.2.4.By Country
6.3.North America: Country Analysis
- 6.3.1.United States Animal Antibiotics and Antimicrobials Market Outlook
  - 6.3.1.1.Market Size Forecast
    - 6.3.1.1.1.By Value
  - 6.3.1.2.Market Share Forecast
    - 6.3.1.2.1.By Product
    - 6.3.1.2.2.By Mode of Delivery
    - 6.3.1.2.3.By Animal Type
- 6.3.2.Canada Animal Antibiotics and Antimicrobials Market Outlook
  - 6.3.2.1.Market Size Forecast
    - 6.3.2.1.1.By Value
  - 6.3.2.2.Market Share Forecast
    - 6.3.2.2.1.By Product
    - 6.3.2.2.2.By Mode of Delivery
    - 6.3.2.2.3.By Animal Type
- 6.3.3.Mexico Animal Antibiotics and Antimicrobials Market Outlook
  - 6.3.3.1.Market Size Forecast
    - 6.3.3.1.1.By Value
  - 6.3.3.2.Market Share Forecast
    - 6.3.3.2.1.By Product
    - 6.3.3.2.2.By Mode of Delivery
    - 6.3.3.2.3.By Animal Type

7.Europe Animal Antibiotics and Antimicrobials Market Outlook

7.1.Market Size Forecast
- 7.1.1.By Value
7.2.Market Share Forecast
- 7.2.1.By Product
- 7.2.2.By Mode of Delivery
- 7.2.3.By Animal Type
- 7.2.4. By Country
7.3.Europe: Country Analysis
- 7.3.1.Germany Animal Antibiotics and Antimicrobials Market Outlook
  - 7.3.1.1.Market Size Forecast
    - 7.3.1.1.1.By Value
  - 7.3.1.2.Market Share Forecast
    - 7.3.1.2.1.By Product
    - 7.3.1.2.2.By Mode of Delivery
    - 7.3.1.2.3.By Animal Type
- 7.3.2.United Kingdom Animal Antibiotics and Antimicrobials Market Outlook
  - 7.3.2.1.Market Size Forecast
    - 7.3.2.1.1.By Value
  - 7.3.2.2.Market Share Forecast
    - 7.3.2.2.1.By Product
    - 7.3.2.2.2.By Mode of Delivery
    - 7.3.2.2.3.By Animal Type
- 7.3.3.Italy Animal Antibiotics and Antimicrobials Market Outlook
  - 7.3.3.1.Market Size Forecast
    - 7.3.3.1.1.By Value
  - 7.3.3.2.Market Share Forecasty
    - 7.3.3.2.1.By Product
    - 7.3.3.2.2.By Mode of Delivery
    - 7.3.3.2.3.By Animal Type
- 7.3.4.France Animal Antibiotics and Antimicrobials Market Outlook
  - 7.3.4.1.Market Size Forecast
    - 7.3.4.1.1.By Value
  - 7.3.4.2.Market Share Forecast
    - 7.3.4.2.1.By Product
    - 7.3.4.2.2.By Mode of Delivery
    - 7.3.4.2.3.By Animal Type
- 7.3.5.Spain Animal Antibiotics and Antimicrobials Market Outlook
  - 7.3.5.1.Market Size Forecast
    - 7.3.5.1.1.By Value
  - 7.3.5.2.Market Share Forecast
    - 7.3.5.2.1.By Product
    - 7.3.5.2.2.By Mode of Delivery
    - 7.3.5.2.3.By Animal Type

8.Asia-Pacific Animal Antibiotics and Antimicrobials Market Outlook

8.1.Market Size Forecast
- 8.1.1.By Value
8.2.Market Share Forecast
- 8.2.1.By Product
- 8.2.2.By Mode of Delivery
- 8.2.3.By Animal Type
- 8.2.4. By Country
8.3.Asia-Pacific: Country Analysis
- 8.3.1.China Animal Antibiotics and Antimicrobials Market Outlook
  - 8.3.1.1.Market Size Forecast
    - 8.3.1.1.1.By Value
  - 8.3.1.2.Market Share Forecast
    - 8.3.1.2.1.By Product
    - 8.3.1.2.2.By Mode of Delivery
    - 8.3.1.2.3.By Animal Type
- 8.3.2.India Animal Antibiotics and Antimicrobials Market Outlook
  - 8.3.2.1.Market Size Forecast
    - 8.3.2.1.1.By Value
  - 8.3.2.2.Market Share Forecast
    - 8.3.2.2.1.By Product
    - 8.3.2.2.2.By Mode of Delivery
    - 8.3.2.2.3.By Animal Type
- 8.3.3.Japan Animal Antibiotics and Antimicrobials Market Outlook
  - 8.3.3.1.Market Size Forecast
    - 8.3.3.1.1.By Value
  - 8.3.3.2.Market Share Forecast
    - 8.3.3.2.1.By Product
    - 8.3.3.2.2.By Mode of Delivery
    - 8.3.3.2.3.By Animal Type
- 8.3.4.South Korea Animal Antibiotics and Antimicrobials Market Outlook
  - 8.3.4.1.Market Size Forecast
    - 8.3.4.1.1.By Value
  - 8.3.4.2.Market Share Forecast
    - 8.3.4.2.1.By Product
    - 8.3.4.2.2.By Mode of Delivery
    - 8.3.4.2.3.By Animal Type
- 8.3.5.Australia Animal Antibiotics and Antimicrobials Market Outlook
  - 8.3.5.1.Market Size Forecast
    - 8.3.5.1.1.By Value
  - 8.3.5.2.Market Share Forecast
    - 8.3.5.2.1.By Product
    - 8.3.5.2.2.By Mode of Delivery
    - 8.3.5.2.3.By Animal Type

9.South America Animal Antibiotics and Antimicrobials Market Outlook

9.1.Market Size Forecast
- 9.1.1.By Value
9.2.Market Share Forecast
- 9.2.1.By Product
- 9.2.2.By Mode of Delivery
- 9.2.3.By Animal Type
- 9.2.4. By Country
9.3.South America: Country Analysis
- 9.3.1.Brazil Animal Antibiotics and Antimicrobials Market Outlook
  - 9.3.1.1.Market Size Forecast
    - 9.3.1.1.1.By Value
  - 9.3.1.2.Market Share Forecast
    - 9.3.1.2.1.By Product
    - 9.3.1.2.2.By Mode of Delivery
    - 9.3.1.2.3.By Animal Type
- 9.3.2.Argentina Animal Antibiotics and Antimicrobials Market Outlook
  - 9.3.2.1.Market Size Forecast
    - 9.3.2.1.1.By Value
  - 9.3.2.2.Market Share Forecast
    - 9.3.2.2.1.By Product
    - 9.3.2.2.2.By Mode of Delivery
    - 9.3.2.2.3.By Animal Type
- 9.3.3.Colombia Animal Antibiotics and Antimicrobials Market Outlook
  - 9.3.3.1.Market Size Forecast
    - 9.3.3.1.1.By Value
  - 9.3.3.2.Market Share Forecast
    - 9.3.3.2.1.By Product
    - 9.3.3.2.2.By Mode of Delivery
    - 9.3.3.2.3.By Animal Type

10.Middle East and Africa Animal Antibiotics and Antimicrobials Market Outlook

10.1.Market Size Forecast
- 10.1.1.By Value
10.2.Market Share Forecast
- 10.2.1.By Product
- 10.2.2.By Mode of Delivery
- 10.2.3.By Animal Type
- 10.2.4.By Country
10.3.MEA: Country Analysis
- 10.3.1.South Africa Animal Antibiotics and Antimicrobials Market Outlook
  - 10.3.1.1.Market Size Forecast
    - 10.3.1.1.1.By Value
  - 10.3.1.2.Market Share Forecast
    - 10.3.1.2.1.By Product
    - 10.3.1.2.2.By Mode of Delivery
    - 10.3.1.2.3.By Animal Type
- 10.3.2.Saudi Arabia Animal Antibiotics and Antimicrobials Market Outlook
  - 10.3.2.1.Market Size Forecast
    - 10.3.2.1.1.By Value
  - 10.3.2.2.Market Share Forecast
    - 10.3.2.2.1.By Product
    - 10.3.2.2.2.By Mode of Delivery
    - 10.3.2.2.3.By Animal Type
- 10.3.3.UAE Animal Antibiotics and Antimicrobials Market Outlook
  - 10.3.3.1.Market Size Forecast
    - 10.3.3.1.1.By Value
  - 10.3.3.2.Market Share Forecast
    - 10.3.3.2.1.By Product
    - 10.3.3.2.2.By Mode of Delivery
    - 10.3.3.2.3.By Animal Type

11.Market Dynamics

11.1.Drivers
11.2.Challenges

12.Market Trends Developments

12.1.Recent Developments
12.2.Product Launches
12.3.Mergers Acquisitions

13.Global Animal Antibiotics and Antimicrobials Market: SWOT Analysis

14.Competitive Landscape

14.1.Boehringer Ingelheim International GmbH
- 14.1.1.Business Overview
- 14.1.2.Product Offerings
- 14.1.3.Recent Developments
- 14.1.4.Financials (As Reported)
- 14.1.5.Key Personnel
- 14.1.6.SWOT Analysis
14.2.Zoetis Services LLC
14.3.Merck co. Inc.
14.4.Elanco Animal Health Incorporated
14.5.Phibro Animal Health Corporation
14.6.Vetoquinol S.A.
14.7.Virbac S.A.
14.8.HIPRA S.A.
14.9.Ceva Sante Animale S.A.
14.10.Kyoritsuseiyaku Corporation.